A synopsis of Lenvatinib

Anniepery28 Jan, 2022Health

Lenvatinib is a tyrosine kinase inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4). It is an anti-tumour medicine, and it is used in treating patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer, patients with advanced renal cell carcinoma (RCC) following one prior antiangiogenic therapy, and patients with unresectable hepatocellular carcinoma. The medicine is supplied in 10 mg and 4 mg capsules for oral administration. Lenvatinib also inhibits other RTKs that have been implicated in pathogenic angiogenesis, tumour growth, and cancer progression. Lenvatinib price is affordable in India, and this medicine is readily available with multiple generic medicine suppliers. The Indian Pharma is one of the licensed suppliers, supplying drugs globally for more than 7 years.

Recent Profiles

Bet88 photo

Bet88 Photo

View Profile

Win606

Win606

View Profile

Hear Again

Hear Again

View Profile

property management dubai

Property Management Dubai

View Profile

The Rush Funplex

The Rush Funplex

View Profile

188V spot

188v Spot

View Profile

Marcella & Co Aesthetics

Marcella & Co Aesthetics

View Profile

HBBet

Hbbet

View Profile

Go 88 audio

Go 88 Audio

View Profile